EK-Pro arrhythmia monitoring uses four simultaneous leads for analysis, including atrial fibrillation detection and trending, to help maximize correct event detection and minimize false alarms.
Continuous ST-segment monitoring of up to 12 leads and ST trend views enable you to detect clinically significant changes rapidly and intervene immediately.
Continuous monitoring of QT/QTc prolongation helps you prevent life-threatening torsades de pointes events.
Optional ACS mode provides higher sensitivity 12SL analysis for the detection of acute coronary syndrome in patients suspected of acute myocardial infarction or ischemia.
Diagnostic quality of 12SL analysis and automatic, initial interpretation, along with two-way integration to the MUSE™ cardiology information system, enable fast, validated access to a patient’s 12SL history and serial comparison of cardiac status.
Up to 72-hour parameter trends allow you to analyze changes in the patient’s status, as well as evaluate the treatment’s effectiveness.
Innovative gas exchange and metabolics technologies, including Patient Spirometry, aid the clinician in optimizing the patient’s nutrition, work of breathing and ventilator settings in order to help the healing and weaning process.
Through PiCCO technology, a less invasive hemodynamic monitoring capability that may help in managing fluid therapy, assessing volume status, assessing cardiac contractility and detecting pulmonary edema in pediatric and adult patients